SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Marker Therapeutics Awarded $16.2 Million CPRIT Grant

The grant will advance MT-601 in the Phase 2 APOLLO study.

MRKR

Related stories